Related Experiment Videos
Cooperative Cardiovascular Project (CCP) quality improvement in Maine, New Hampshire, and Vermont
L D Ramunno1, T A Dodds, N D Traven
1Northeast Health Care Quality Foundation.
Insights
The Cooperative Cardiovascular Project (CCP) improved acute myocardial infarction (AMI) care in Medicare patients through quality indicator feedback. Key treatments like aspirin and beta-blockers saw significant performance gains post-intervention.
Area of Science:
- Cardiovascular Medicine
- Healthcare Quality Improvement
- Public Health
Background:
- The Cooperative Cardiovascular Project (CCP) is a nationwide initiative focused on improving care for Medicare patients experiencing acute myocardial infarction (AMI).
- Quality improvement projects utilize measurement, feedback, and remeasurement to drive healthcare enhancements.
Purpose of the Study:
- To assess the impact of the CCP's quality improvement cycle on AMI patient care in Maine, New Hampshire, and Vermont.
- To evaluate changes in adherence to specific quality indicators following intervention.
Main Methods:
- Data from 3,472 baseline AMI patient records were collected from 76 hospitals (Jan 1994-Feb 1995).
- Following feedback, 2,270 remeasurement records were collected (Oct 1996-May 1997).
- Performance on quality indicators was compared between baseline and remeasurement phases.
Main Results:
- Significant improvements were observed in aspirin administration during hospitalization (88% to 93%) and at discharge (83% to 90%).
- Use of discharge beta-blockers increased significantly (69% to 82%).
- Thrombolytic timing and calcium channel blocker avoidance also showed significant improvements.
Conclusions:
- Evidence-based indicators, combined with national data collection and local interventions, can significantly enhance acute myocardial infarction care.
- The CCP demonstrates a successful model for quality improvement in cardiovascular medicine.
Abstract:
The Cooperative Cardiovascular Project (CCP) is a nationwide quality improvement project (quality indicator measurement, feedback, remeasurement) in Medicare acute myocardial infarction (AMI) patients sponsored by the Health Care Financing Administration (HCFA). In Maine, New Hampshire, and Vermont, 3,472 baseline records were abstracted from 76 hospitals from January 1994 to February 1995. After feedback, 2,270 remeasurements were collected from October 1996 to May 1997. At remeasurement, performance improved significantly for "ideal" candidates (defined by the CCP) on five quality indicators--aspirin during hospitalization 88% to 93% (p < .001), thrombolytic timing 60% to 69% (p < .01), discharge aspirin 83% to 90% (p < .001), discharge beta-blockers 69% to 82% (p < .01), and calcium channel blocker avoidance 83% to 93% (p < .05). Reperfusion, angiotensin converting enzyme inhibitors, and smoking cessation advice did not improve significantly. This study demonstrates that evidence-based indicators, nationally designed data collection, and locally based interventions can significantly improve AMI care.